BCR and lymphoma: Despite its demonstrated positive impact on BCR signaling, as shown in our current study and by refs. 20,54, our data also revealed the inhibitory function of CEACAM1 in the lymphoma cell lines with low or no CEACAM1 expression, consistent with previous reports47–49.